These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Construction of Histidine-Enriched Shark IgNAR Variable Domain Antibody Libraries for the Isolation of pH-Sensitive vNAR Fragments. Könning D; Hinz S; Grzeschik J; Schröter C; Krah S; Zielonka S; Kolmar H Methods Mol Biol; 2018; 1827():109-127. PubMed ID: 30196494 [TBL] [Abstract][Full Text] [Related]
5. The Shark Strikes Twice: Hypervariable Loop 2 of Shark IgNAR Antibody Variable Domains and Its Potential to Function as an Autonomous Paratope. Zielonka S; Empting M; Könning D; Grzeschik J; Krah S; Becker S; Dickgießer S; Kolmar H Mar Biotechnol (NY); 2015 Aug; 17(4):386-92. PubMed ID: 26003538 [TBL] [Abstract][Full Text] [Related]
6. Isolation and Characterization of Targeting-HBsAg VNAR Single Domain Antibodies from Whitespotted Bamboo Sharks ( Jiang X; Sun S; Li Z; Chen M Mar Drugs; 2023 Apr; 21(4):. PubMed ID: 37103376 [TBL] [Abstract][Full Text] [Related]
7. Synthetic libraries of shark vNAR domains with different cysteine numbers within the CDR3. Cabanillas-Bernal O; Dueñas S; Ayala-Avila M; Rucavado A; Escalante T; Licea-Navarro AF PLoS One; 2019; 14(6):e0213394. PubMed ID: 31206542 [TBL] [Abstract][Full Text] [Related]
8. Transcriptomic analysis of immunoglobulin novel antigen receptor (IgNAR) heavy chain constant domains of brownbanded bamboo shark (Chiloscyllium punctatum). De Silva DPN; Tan E; Mizuno N; Hosoya S; Reza MS; Watabe S; Kinoshita S; Asakawa S Fish Shellfish Immunol; 2019 Jan; 84():370-376. PubMed ID: 30291985 [TBL] [Abstract][Full Text] [Related]
9. Characterization and humanization of VNARs targeting human serum albumin from the whitespotted bamboo shark (Chiloscyllium plagiosum). Li W; Chen M; Wang T; Feng X; Jiang X; Dong X; Zhang H; Tang X; Tian R; Zhang Y; Li Z Int J Biol Macromol; 2024 Jul; 273(Pt 2):133082. PubMed ID: 38878923 [TBL] [Abstract][Full Text] [Related]
10. Improving the pharmacokinetic properties of biologics by fusion to an anti-HSA shark VNAR domain. Müller MR; Saunders K; Grace C; Jin M; Piche-Nicholas N; Steven J; O'Dwyer R; Wu L; Khetemenee L; Vugmeyster Y; Hickling TP; Tchistiakova L; Olland S; Gill D; Jensen A; Barelle CJ MAbs; 2012; 4(6):673-85. PubMed ID: 23676205 [TBL] [Abstract][Full Text] [Related]
11. Specific Targeting of Lymphoma Cells Using Semisynthetic Anti-Idiotype Shark Antibodies. Macarrón Palacios A; Grzeschik J; Deweid L; Krah S; Zielonka S; Rösner T; Peipp M; Valerius T; Kolmar H Front Immunol; 2020; 11():560244. PubMed ID: 33324393 [TBL] [Abstract][Full Text] [Related]